Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Pfizer's Braftovi regimen significantly extends survival for colon cancer patients. While this breakthrough is promising for healthcare, it also raises questions about its ripple effect on biotech investments and even cryptocurrency markets.